CN101812076A - Cefuroxime sodium and preparation method thereof - Google Patents
Cefuroxime sodium and preparation method thereof Download PDFInfo
- Publication number
- CN101812076A CN101812076A CN 200910118718 CN200910118718A CN101812076A CN 101812076 A CN101812076 A CN 101812076A CN 200910118718 CN200910118718 CN 200910118718 CN 200910118718 A CN200910118718 A CN 200910118718A CN 101812076 A CN101812076 A CN 101812076A
- Authority
- CN
- China
- Prior art keywords
- acid
- cefuroxime
- crystallization
- sodium
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
The invention provides cefuroxime sodium and a preparation method thereof. The preparation method comprises the following steps that: (1) 7-aminocephalosporanic acid reacts with 2-(furan-2-base)-2-(methoxyimino) acetyl chloride to produce 3-deacety-7-aminocephalosporanic acid; (2) crystallization is conducted after the 3-deacety-7-aminocephalosporanic acid reacts with chlorosulfonyl isocyanate to produce cefuroxime acid; and (3) the cefuroxime acid is salified to obtain the cefuroxime sodium, wherein solvent for crystallization is selected from one or more of petroleum ether, normal hexane, cyclohexane, solvent oil and tetrahydrofuran. Since the preparation method adopts solvents such as petroleum ether for crystallization in the process of the preparation of the cefuroxime acid, the invention has the advantages that the yield of the product is effectively improved, the product purity is further improved, the impurity content is reduced, the product quality is compliant with Chinese Pharmacopoeia of version 2005, the operation of the method is simple, the raw materials can be easily obtained, the cost is relatively low and the industrial production can be realized easily.
Description
Technical field
The invention belongs to technical field of medicine synthesis, relate to a kind of cephalosporins and preparation method thereof, be specifically related to Cefuroxime sodium and preparation method thereof.
Background technology
Cefuroxime sodium is the sodium salt of cephalofruxin, belongs to second generation cephalosporin class antibiotic medicine.Its has a broad antifungal spectrum, effective to most of Gram-negative bacterias, comprise the positive sex change bacillus of hemophilus influenzae, gonococcus, meningococcus, intestinal bacteria, klebsiella spp, Proteus mirabilis, enterobacteria, citrobacter, Salmonella, Shigella and some indoles etc.Antimicrobial spectrum to gram-positive microorganism is similar to Cephalexin Monohydrate Micro/Compacted, mainly comprises staphylococcus and suis.This product is comparatively stable to β-Nei Xiananmei, its stability is not second to third generation cephalosporin, stable to nearly all standard enzyme and the β-Nei Xiananmei that extracts from clinical isolating negative bacillus, the bacterium of many product β-Nei Xiananmeis comprises that Gram-positive and negative bacterium are all to its sensitivity.This product is stable to the negative bacillus enzyme, anti-negative bacillus effect is suitable with third generation cephalosporin, and stable to golden Portugal bacterium enzyme, the bacterium effect of anti-golden Portugal is better than third generation cephalosporin, and these advantages make it become the first-selected medication of treatment Gram-negative bacteria or the polyinfection of gram-negative positive bacteria.In addition, this product also has good pharmacokinetic properties, and wide, characteristics such as tissue permeability is good, intramuscular injection bioavailability height, renal toxicity are lower distribute in low as protein binding rate, free blood concentration height, the body.
Chinese invention patent application CN101054386A discloses a kind of synthetic method of Cefuroxime sodium; this method may further comprise the steps: will be 3-deacetylation-7-amino-cephalosporanic acid and cis-2-(furans-2-yl)-2-(methoxyimino) excess acetyl chloride that raw material makes with 7-amino-cephalosporanic acid (7-ACA); generate the 3-formyl radical cefuroxime acid that deaminizes; the 3-formyl radical cefuroxime acid that deaminizes obtains cefuroxime acid with chlorosulfonic acid isocyanate reaction again, behind the direct salify of cefuroxime acid through the refining Cefuroxime sodium finished product that obtains.In this synthetic method, the unprocessed direct salify of the intermediate product cefuroxime acid of generation causes product yield on the low side, only is 85%.
Summary of the invention
Therefore, the purpose of this invention is to provide a kind of preparation method who improves the Cefuroxime sodium of product yield and purity.
Be used to realize that the technical scheme of above-mentioned purpose of the present invention is as follows:
A kind of preparation method of Cefuroxime sodium, it may further comprise the steps:
(1) 7-amino-cephalosporanic acid and 2-(furans-2-yl)-2-(methoxyimino) excess acetyl chloride generates 3-deacetylation-7-amino-cephalosporanic acid;
(2) carry out crystallization operation after the reaction of 3-deacetylation-7-amino-cephalosporanic acid and chlorosulfonic acid isocyanate generates cefuroxime acid;
(3) the cefuroxime acid salify obtains Cefuroxime sodium,
Wherein the solvent of crystallization employing is selected from one or more in sherwood oil, normal hexane, hexanaphthene, solvent oil and the tetrahydrofuran (THF).
In above-mentioned preparation method, solvent is preferably sherwood oil.
Above-mentioned preparation method can also comprise the step of the concentrating under reduced pressure reaction product before the crystallization and/or the drying step after the crystallization.
Specifically, above-mentioned preparation method may further comprise the steps:
(1) 7-amino-cephalosporanic acid being dissolved in pH in 8.0～10.0 the alkaline aqueous solution, carries out condensation reaction with methoxy imino furans ammonium acetate and phosphorus pentachloride and makes 3-deacetylation-7-amino-cephalosporanic acid;
(2) in 3-deacetylation-7-amino-cephalosporanic acid solution, drip chlorosulfonic acid isocyanate, react under the low temperature, add sour adjust pH to 1.0～3.0, reaction generates cefuroxime acid, underpressure distillation concentrates the back and adds the sherwood oil crystallization, and suction filtration, drying obtain cefuroxime acid;
(3) with cefuroxime acid with after proper amount of acetone and the water stirring and dissolving, add the charcoal absorption decolouring, filter the back and add the mixed sodium salts solution and generate Cefuroxime sodium, drip the acetone crystallization, suction filtration, drying makes the Cefuroxime sodium finished product.
In a specific embodiments of the present invention, above-mentioned preparation method can may further comprise the steps:
(1) 7-amino-cephalosporanic acid is added in the entry, regulate pH to 8.0～10.0 with 15% (weight/volume) NaOH solution, it is dissolved fully, carry out condensation reaction with methoxy imino furans ammonium acetate and phosphorus pentachloride, the dripping hydrochloric acid crystallization, suction filtration, drying make 3-deacetylation-7-amino-cephalosporanic acid;
(2) 3-deacetylation-7-amino-cephalosporanic acid is dissolved in the tetrahydrofuran (THF), stir cooling, drip chlorosulfonic acid isocyanate, kept low-temp reaction 0.5～1.5 hour, dripping hydrochloric acid adjust pH to 1.0～3.0, reaction generates cefuroxime acid, and underpressure distillation concentrates, add the sherwood oil crystallization, suction filtration, drying obtain cefuroxime acid;
(3) with after cefuroxime acid usefulness proper amount of acetone and the water stirring and dissolving, add the charcoal absorption decolouring, filter, add the mixed sodium salts solution that comprises Sodium isooctanoate, sodium-acetate and Sodium.alpha.-hydroxypropionate in the filtrate and generate Cefuroxime sodium, drip the acetone crystallization, suction filtration, drying makes the Cefuroxime sodium finished product.
Above-mentioned preparation method's concrete synthetic route is as follows:
2-(furans-2-yl)-2-(methoxyimino) Acetyl Chloride 98Min. 3-deacetylation-7-amino-cephalosporanic acid
Preparation method with respect to existing Cefuroxime sodium, preparation method of the present invention has adopted the sherwood oil equal solvent to carry out crystallization in the process of preparation cefuroxime acid, improved the yield of product effectively, product purity further improves, and foreign matter content reduces, and quality product meets 2005 editions " regulations of Chinese pharmacopoeia, and this method is simple to operate, raw material is easy to get, and cost is relatively low, realizes suitability for industrialized production easily.
Embodiment
The preparation of embodiment 1:3-deacetylation-7-amino-cephalosporanic acid
Add 230ml purified water and 50g 7-ACA (7-amino-cephalosporanic acid) in four-hole bottle, temperature control drips 15% (weight/volume) NaOH solution for 0～5 ℃, transfers pH to 8.0～10.0, dissolves it stand-by fully; Add phosphorus pentachloride 51.3g in another four-hole bottle, methylene dichloride 350ml, temperature control-12 ℃ adding N,N-DIMETHYLACETAMIDE (DMA) 75ml, furfuran amine salt (being methoxy imino furans ammonium acetate) 41g, insulation reaction 1 hour, add purified water 175ml, standing demix behind the stirring 10min is integrated with organic phase in the 7-ACA solution, 0～10 ℃ of reaction of temperature control 3 hours, and drip 15% (weight/volume) NaOH solution keep pH value of reaction system in 6～8 scopes to reacting completely standing demix.Water adds the 250ml methylene dichloride, stirs fast, and 10min drips 15% (weight/volume) HCl solution and transfers pH to 2.0 crystallization.Suction filtration, vacuum-drying 15 hours obtains 3-deacetylation-7-amino-cephalosporanic acid.It is 98.5% that HPLC detects purity, and maximum contaminant content is 0.5%.
Embodiment 2: the preparation of cefuroxime acid
3-deacetylation-the 7-amino-cephalosporanic acid that makes is dropped in the 1000ml four-hole bottle; add tetrahydrofuran (THF) 240ml; temperature control is to-40～-50 ℃ of adding chlorosulfonic acid isocyanate 15.8ml; behind the insulation reaction 40min; it is complete with excessive chlorosulfonic acid isocyanate hydrolysis to add the 54ml purified water, adds 53gNaHCO
3, stirring 10min, standing demix is abandoned water, organic phase drips 30% (weight/volume) HCl solution 16ml and transfers pH to 2.0, adds the 5g gac and stirs the 10min filtration, has been evaporated to crystal and has separated out in a small amount, adds the sherwood oil crystallization, suction filtration, vacuum-drying 4 hours obtains cefuroxime acid.Purity is 99.0%, maximum contaminant content 0.2%.
Embodiment 3: the preparation of cefuroxime acid sodium
In the 500ml there-necked flask, add acetone 200ml, purified water 30ml, drop into cefuroxime acid 40g, temperature control is stirred to molten entirely for 25 ℃, add the 4g gac, suction filtration, temperature control 25～-30 add ℃ in filtrate dissolves Sodium isooctanoate completely, sodium-acetate and Sodium.alpha.-hydroxypropionate mixing solutions add and stir 15min, drip acetone 600ml crystallization, stir the 30min growing the grain at a slow speed, suction filtration, washing with acetone, 40 ℃ of dryings 2 hours obtain Cefuroxime sodium finished product 39.9g, yield reaches 99.75%, purity is 99.8%, and maximum contaminant content is 0.2%, and quality meets 2005 editions " regulations of Chinese pharmacopoeia.
Claims (6)
1. the preparation method of a Cefuroxime sodium, it may further comprise the steps:
(1) 7-amino-cephalosporanic acid and 2-(furans-2-yl)-2-(methoxyimino) excess acetyl chloride generates 3-deacetylation-7-amino-cephalosporanic acid;
(2) carry out crystallization operation after the reaction of 3-deacetylation-7-amino-cephalosporanic acid and chlorosulfonic acid isocyanate generates cefuroxime acid;
(3) the cefuroxime acid salify obtains Cefuroxime sodium,
Wherein the solvent of crystallization employing is selected from one or more in sherwood oil, normal hexane, hexanaphthene, solvent oil and the tetrahydrofuran (THF).
2. preparation method according to claim 1 is characterized in that, described solvent is a sherwood oil.
3. preparation method according to claim 1 and 2 is characterized in that, described preparation method also comprises the step of the concentrating under reduced pressure reaction product before the crystallization.
4. according to each described preparation method in the claim 1 to 3, it is characterized in that described preparation method also comprises the drying step after the crystallization.
5. according to each described preparation method in the claim 1 to 4, it is characterized in that described preparation method may further comprise the steps:
(1) 7-amino-cephalosporanic acid being dissolved in pH in 8.0～10.0 the alkaline aqueous solution, carries out condensation reaction with methoxy imino furans ammonium acetate and phosphorus pentachloride and makes 3-deacetylation-7-amino-cephalosporanic acid;
(2) in 3-deacetylation-7-amino-cephalosporanic acid solution, drip chlorosulfonic acid isocyanate, react under the low temperature, add sour adjust pH to 1.0～3.0, reaction generates cefuroxime acid, underpressure distillation concentrates the back and adds the sherwood oil crystallization, and suction filtration, drying obtain cefuroxime acid;
(3) with cefuroxime acid with after proper amount of acetone and the water stirring and dissolving, add the charcoal absorption decolouring, filter the back and add the mixed sodium salts solution and generate Cefuroxime sodium, drip the acetone crystallization, suction filtration, drying makes the Cefuroxime sodium finished product.
6. according to each described preparation method in the claim 1 to 5, it is characterized in that described preparation method may further comprise the steps:
(1) 7-amino-cephalosporanic acid is added in the entry, regulate pH to 8.0～10.0 with 15% (weight/volume) NaOH solution, after it is dissolved fully, carry out condensation reaction with methoxy imino furans ammonium acetate and phosphorus pentachloride, the dripping hydrochloric acid crystallization, suction filtration, drying make 3-deacetylation-7-amino-cephalosporanic acid;
(2) 3-deacetylation-7-amino-cephalosporanic acid is dissolved in the tetrahydrofuran (THF), stir cooling, drip chlorosulfonic acid isocyanate, kept low-temp reaction 0.5～1.5 hour, dripping hydrochloric acid adjust pH to 1.0～3.0, reaction generates cefuroxime acid, and underpressure distillation concentrates, add the sherwood oil crystallization, suction filtration, drying obtain cefuroxime acid;
(3) with after cefuroxime acid usefulness proper amount of acetone and the water stirring and dissolving, add the charcoal absorption decolouring, filter, add the mixed sodium salts solution that comprises Sodium isooctanoate, sodium-acetate and Sodium.alpha.-hydroxypropionate in the filtrate and generate Cefuroxime sodium, drip the acetone crystallization, suction filtration, drying makes the Cefuroxime sodium finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910118718 CN101812076B (en) | 2009-02-24 | 2009-02-24 | Cefuroxime sodium and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910118718 CN101812076B (en) | 2009-02-24 | 2009-02-24 | Cefuroxime sodium and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101812076A true CN101812076A (en) | 2010-08-25 |
| CN101812076B CN101812076B (en) | 2012-05-30 |
Family
ID=42619454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200910118718 Active CN101812076B (en) | 2009-02-24 | 2009-02-24 | Cefuroxime sodium and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101812076B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102617604A (en) * | 2012-02-24 | 2012-08-01 | 天津大学 | Method utilizing coupling reaction crystallization to prepare cefuroxime sodium |
| CN102702231A (en) * | 2012-06-18 | 2012-10-03 | 山东大学 | Method for preparing 3-descarbamoyl-cefuroxime acid |
| CN103102357A (en) * | 2013-02-21 | 2013-05-15 | 广东立国制药有限公司 | Synthesis method of cefuroxime sodium |
| CN104774211A (en) * | 2015-04-27 | 2015-07-15 | 四川制药制剂有限公司 | Preparation technique of cefuroxime sodium for injection |
| CN105669700A (en) * | 2016-02-18 | 2016-06-15 | 海南灵康制药有限公司 | Cefuroxime sodium new crystal type compound and preparation adopting particle process crystal product molecular assembly and form optimizing technology |
| CN106565748A (en) * | 2016-09-30 | 2017-04-19 | 华北制药河北华民药业有限责任公司 | Preparation method for cefuroxime sodium and preparation thereof |
| CN107652306A (en) * | 2017-10-24 | 2018-02-02 | 北京红太阳药业有限公司 | A kind of Cefuroxime Sodium crystal-form compound |
| CN110483553A (en) * | 2019-08-12 | 2019-11-22 | 上海龙翔生物医药开发有限公司 | A kind of stable Cefuroxime Sodium and preparation method thereof |
| CN110950892A (en) * | 2019-12-16 | 2020-04-03 | 山东金城柯瑞化学有限公司 | Method for optimizing and removing impurities from cefuroxime intermediate (3-decarbamoyl-cefuroxime acid) |
| CN115353524A (en) * | 2022-08-25 | 2022-11-18 | 浙江东盈药业有限公司 | Synthesis method of cefuroxime sodium |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040092735A1 (en) * | 2002-11-08 | 2004-05-13 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of cefuroxime sodium |
| CN100564382C (en) * | 2006-11-12 | 2009-12-02 | 西南合成制药股份有限公司 | The synthetic method of Cefuroxime sodium |
-
2009
- 2009-02-24 CN CN 200910118718 patent/CN101812076B/en active Active
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102617604A (en) * | 2012-02-24 | 2012-08-01 | 天津大学 | Method utilizing coupling reaction crystallization to prepare cefuroxime sodium |
| CN102702231A (en) * | 2012-06-18 | 2012-10-03 | 山东大学 | Method for preparing 3-descarbamoyl-cefuroxime acid |
| CN102702231B (en) * | 2012-06-18 | 2014-10-29 | 山东大学 | Method for preparing 3-descarbamoyl-cefuroxime acid |
| CN103102357A (en) * | 2013-02-21 | 2013-05-15 | 广东立国制药有限公司 | Synthesis method of cefuroxime sodium |
| CN103102357B (en) * | 2013-02-21 | 2016-01-13 | 广东立国制药有限公司 | A kind of synthetic method of Cefuroxime sodium |
| CN104774211A (en) * | 2015-04-27 | 2015-07-15 | 四川制药制剂有限公司 | Preparation technique of cefuroxime sodium for injection |
| CN105669700A (en) * | 2016-02-18 | 2016-06-15 | 海南灵康制药有限公司 | Cefuroxime sodium new crystal type compound and preparation adopting particle process crystal product molecular assembly and form optimizing technology |
| WO2017140072A1 (en) * | 2016-02-18 | 2017-08-24 | 海南灵康制药有限公司 | Novel polymorphic cefuroxime sodium compound and preparation employing particle process crystal product molecular assembly and morphological optimization technique |
| CN106565748A (en) * | 2016-09-30 | 2017-04-19 | 华北制药河北华民药业有限责任公司 | Preparation method for cefuroxime sodium and preparation thereof |
| CN107652306A (en) * | 2017-10-24 | 2018-02-02 | 北京红太阳药业有限公司 | A kind of Cefuroxime Sodium crystal-form compound |
| CN110483553A (en) * | 2019-08-12 | 2019-11-22 | 上海龙翔生物医药开发有限公司 | A kind of stable Cefuroxime Sodium and preparation method thereof |
| CN110950892A (en) * | 2019-12-16 | 2020-04-03 | 山东金城柯瑞化学有限公司 | Method for optimizing and removing impurities from cefuroxime intermediate (3-decarbamoyl-cefuroxime acid) |
| CN115353524A (en) * | 2022-08-25 | 2022-11-18 | 浙江东盈药业有限公司 | Synthesis method of cefuroxime sodium |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101812076B (en) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101812076B (en) | Cefuroxime sodium and preparation method thereof | |
| CN102219795B (en) | Method for preparing ceftezole sodium | |
| CN102134252B (en) | Preparation method of high-purity cefuroxime acid | |
| CN102617607B (en) | Method for preparing cefazolin compounds | |
| CN103709179B (en) | A kind of synthesizing progress method of cefmetazole sodium | |
| CN101108856A (en) | Method of synthesizing antibiotics cefamandole nafate | |
| CN105017286A (en) | Preparation method for cephalosporin anti-infective drug | |
| CN101735250B (en) | Synthesis method of ceftezole sodium compound | |
| CN104447800A (en) | Synthesis technology of cefoxitin acid | |
| CN101220040A (en) | Preparation of cefixime cephalosporin and fine purification method | |
| CN102153566B (en) | Method for preparing cefdinir | |
| CN103319503A (en) | Preparation method of cefdinir | |
| CN103030651A (en) | Method for preparing ceftazidime hydrochloride | |
| CN101906109B (en) | Method for preparing cefuroxime sodium | |
| CN101550146A (en) | Cefetamet pivoxil hydrochloride compound and preparation method thereof | |
| CN104130272A (en) | Improvement method of cefalexin synthesis process | |
| CN109553626B (en) | Refining method of ceftizoxime sodium | |
| CN110117291B (en) | Synthesis method of cefotaxime acid | |
| CN107266473A (en) | A kind of synthetic method of cefotaxime | |
| CN102911186B (en) | Ceftizoxime sodium preparation and refining method | |
| CN108033971B (en) | Method for synthesizing cefcapene pivoxil hydrochloride | |
| CN113387960B (en) | Refining method of latamoxef sodium intermediate | |
| CN104230956B (en) | A kind of preparation method of cefoxitin | |
| CN103374019B (en) | A kind of preparation method of Cefuroxime Sodium | |
| CN1155603C (en) | Process for producing 3-cephem compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |